CDH2
Summary: This gene encodes a classical cadherin and member of the cadherin superfamily. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein is proteolytically processed to generate a calcium-dependent cell adhesion molecule and glycoprotein. This protein plays a role in the establishment of left-right asymmetry, development of the nervous system and the formation of cartilage and bone. [provided by RefSeq, Nov 2015].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
cadherin 2 | MIM:114020 | Ensembl:ENSG00000170558 | HGNC:HGNC:1759 | PA26293 | 18q12.1 |
GO terms in CDH2
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
BP | IBA | GO:0000902 | cell morphogenesis |
BP | IBA | GO:0007043 | cell-cell junction assembly |
BP | TAS | GO:0007155 | cell adhesion |
BP | IBA | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules |
BP | IEA | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules |
BP | IEA | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
BP | IBA | GO:0007275 | multicellular organism development |
BP | IBA | GO:0007416 | synapse assembly |
BP | IBA | GO:0007420 | brain development |
BP | ISS | GO:0010001 | glial cell differentiation |
BP | IBA | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
BP | IEA | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
BP | IEA | GO:0016477 | cell migration |
BP | IEA | GO:0021987 | cerebral cortex development |
BP | IBA | GO:0034332 | adherens junction organization |
BP | TAS | GO:0034332 | adherens junction organization |
BP | IEA | GO:0043410 | positive regulation of MAPK cascade |
BP | TAS | GO:0043687 | post-translational protein modification |
BP | TAS | GO:0044267 | cellular protein metabolic process |
BP | IBA | GO:0044331 | cell-cell adhesion mediated by cadherin |
BP | ISS | GO:0044331 | cell-cell adhesion mediated by cadherin |
BP | IBA | GO:0048514 | blood vessel morphogenesis |
BP | IEA | GO:0048514 | blood vessel morphogenesis |
BP | IEA | GO:0048854 | brain morphogenesis |
BP | IEA | GO:0048872 | homeostasis of number of cells |
BP | IBA | GO:0050770 | regulation of axonogenesis |
BP | IEA | GO:0051146 | striated muscle cell differentiation |
BP | TAS | GO:0051149 | positive regulation of muscle cell differentiation |
BP | IBA | GO:0051966 | regulation of synaptic transmission, glutamatergic |
BP | IEA | GO:0060019 | radial glial cell differentiation |
BP | IEA | GO:0060563 | neuroepithelial cell differentiation |
BP | IEA | GO:0070445 | regulation of oligodendrocyte progenitor proliferation |
BP | IEA | GO:0072659 | protein localization to plasma membrane |
BP | IEA | GO:0090090 | negative regulation of canonical Wnt signaling pathway |
BP | IEA | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly |
BP | ISS | GO:0097150 | neuronal stem cell population maintenance |
BP | IEA | GO:1902897 | regulation of postsynaptic density protein 95 clustering |
BP | IEA | GO:2000809 | positive regulation of synaptic vesicle clustering |
CC | IBA | GO:0005737 | cytoplasm |
CC | IDA | GO:0005737 | cytoplasm |
CC | TAS | GO:0005788 | endoplasmic reticulum lumen |
CC | IBA | GO:0005886 | plasma membrane |
CC | IDA | GO:0005886 | plasma membrane |
CC | TAS | GO:0005886 | plasma membrane |
CC | IDA | GO:0005911 | cell-cell junction |
CC | IBA | GO:0005913 | cell-cell adherens junction |
CC | IDA | GO:0005913 | cell-cell adherens junction |
CC | IEA | GO:0005916 | fascia adherens |
CC | HDA | GO:0005925 | focal adhesion |
CC | IBA | GO:0009986 | cell surface |
CC | ISS | GO:0009986 | cell surface |
CC | IBA | GO:0014069 | postsynaptic density |
CC | IEA | GO:0014069 | postsynaptic density |
CC | IBA | GO:0014704 | intercalated disc |
CC | ISS | GO:0014704 | intercalated disc |
CC | IEA | GO:0016021 | integral component of membrane |
CC | IEA | GO:0016323 | basolateral plasma membrane |
CC | IEA | GO:0016324 | apical plasma membrane |
CC | IBA | GO:0016342 | catenin complex |
CC | IDA | GO:0016342 | catenin complex |
CC | IBA | GO:0030027 | lamellipodium |
CC | IDA | GO:0030027 | lamellipodium |
CC | IDA | GO:0030054 | cell junction |
CC | IDA | GO:0030864 | cortical actin cytoskeleton |
CC | IEA | GO:0042383 | sarcolemma |
CC | IBA | GO:0042734 | presynaptic membrane |
CC | IBA | GO:0043005 | neuron projection |
CC | IEA | GO:0044853 | plasma membrane raft |
CC | IBA | GO:0045177 | apical part of cell |
CC | IBA | GO:0045202 | synapse |
CC | HDA | GO:0062023 | collagen-containing extracellular matrix |
CC | IBA | GO:0099059 | integral component of presynaptic active zone membrane |
CC | IBA | GO:0099060 | integral component of postsynaptic specialization membrane |
MF | IBA | GO:0005509 | calcium ion binding |
MF | IEA | GO:0005509 | calcium ion binding |
MF | IPI | GO:0005515 | protein binding |
MF | IPI | GO:0008013 | beta-catenin binding |
MF | TAS | GO:0008013 | beta-catenin binding |
MF | IBA | GO:0008092 | cytoskeletal protein binding |
MF | IEA | GO:0019901 | protein kinase binding |
MF | IEA | GO:0019903 | protein phosphatase binding |
MF | IEA | GO:0042802 | identical protein binding |
MF | IBA | GO:0042803 | protein homodimerization activity |
MF | IPI | GO:0045294 | alpha-catenin binding |
MF | IPI | GO:0045295 | gamma-catenin binding |
MF | IBA | GO:0045296 | cadherin binding |
Gene expression in normal tissue: CDH2
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in CDH2
Database | Pathway ID | Pathway Des. |
---|---|---|
reactome | R-HSA-1266738 | Developmental Biology |
reactome | R-HSA-1266738 | Developmental Biology |
reactome | R-HSA-1500931 | Cell-Cell communication |
reactome | R-HSA-375170 | CDO in myogenesis |
reactome | R-HSA-375170 | CDO in myogenesis |
reactome | R-HSA-381426 | Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
reactome | R-HSA-392499 | Metabolism of proteins |
reactome | R-HSA-418990 | Adherens junctions interactions |
reactome | R-HSA-421270 | Cell-cell junction organization |
reactome | R-HSA-446728 | Cell junction organization |
reactome | R-HSA-525793 | Myogenesis |
reactome | R-HSA-525793 | Myogenesis |
reactome | R-HSA-597592 | Post-translational protein modification |
reactome | R-HSA-8957275 | Post-translational protein phosphorylation |
wikipathways | WP2064 | Neural Crest Differentiation |
wikipathways | WP2118 | Arrhythmogenic Right Ventricular Cardiomyopathy |
wikipathways | WP2380 | Brain-Derived Neurotrophic Factor (BDNF) signaling pathway |
wikipathways | WP2572 | Primary Focal Segmental Glomerulosclerosis FSGS |
wikipathways | WP4148 | Splicing factor NOVA regulated synaptic proteins |
wikipathways | WP4239 | EMT transition in Colorectal Cancer |
kegg | hsa04514 | Cell adhesion molecules (CAMs) - Homo sapiens (human) |
kegg | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human) |
pid | ajdiss_2pathway | Posttranslational regulation of adherens junction stability and dissassembly |
pid | fgf_pathway | FGF signaling pathway |
pid | ncadherinpathway | N-cadherin signaling events |
pid | ptp1bpathway | Signaling events mediated by PTP1B |
netpath | Pathway_EGFR1 | EGFR1 |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD367 | Ro 28-1675 | 1 |
iGMDRD82 | Quiflapon | 5 |
iGMDRD322 | FK 866 | 2 |
iGMDRD505 | Pevonedistat | 8 |
iGMDRD263 | AACOCF3 | 1 |
iGMDRD5 | Tyrphostin AG 1478 | 2 |
iGMDRD103 | SN-38 | 2 |
iGMDRD271 | Brefeldin A | 3 |
iGMDRD121 | GMX1778 | 4 |
iGMDRD415 | LE-135 | 3 |
iGMDRD481 | Dactolisib | 5 |
iGMDRD105 | Triptolide | 3 |
iGMDRD57 | Chloropentafluorobenzene | 2 |
iGMDRD237 | ABT-751 | 12 |
iGMDRD945 | ML214 | 2 |
iGMDRD435 | BI-2536 | 3 |
iGMDRD901 | ELCPK | 2 |
iGMDRD123 | Isoevodiamine | 2 |
iGMDRD584 | VER 155008 | 1 |
iGMDRD84 | Lovastatin acid | 3 |
iGMDRD307 | Manumycin A | 3 |
iGMDRD523 | Cyanoquinoline, 11 | 10 |
iGMDRD701 | NVP-AUY922 | 2 |
iGMDRD424 | Tamatinib | 9 |
iGMDRD562 | Navitoclax | 4 |
iGMDRD780 | PP-30 | 2 |
iGMDRD399 | Selumetinib | 2 |
iGMDRD60 | Quinoclamine | 9 |
iGMDRD64 | Parbendazole | 8 |
iGMDRD255 | SB225002 | 2 |
iGMDRD613 | CHEMBL258148 | 1 |
iGMDRD885 | Compound 110 | 1 |
iGMDRD801 | 2,4-dideoxy-DC-45-A2 | 3 |
iGMDRD52 | Rotenone | 2 |
iGMDRD207 | Capsaicin | 1 |
iGMDRD446 | LY 2183240 | 6 |
iGMDRD201 | SKI II | 2 |
iGMDRD394 | BX-795 | 1 |
iGMDRD280 | CYTOCHALASIN B | 9 |
iGMDRD151 | CHM-1 | 2 |
iGMDRD554 | CHEMBL1434137 | 8 |
iGMDRD781 | Sirolimus | 1 |
iGMDRD427 | ABT737 | 3 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in CDH2